Cargando…
Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol Disorder
Several clinical randomized trials have evaluated the interest of baclofen in patients with alcohol use disorder. Depending on the study design and the inclusion criteria, the results vary from enthusiastic to pessimistic. However, all researchers and practitioners agree that they observe a wide var...
Autores principales: | Simon, Nicolas, Franchitto, Nicolas, Rolland, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186984/ https://www.ncbi.nlm.nih.gov/pubmed/30349489 http://dx.doi.org/10.3389/fpsyt.2018.00485 |
Ejemplares similares
-
How to Manage Self-Poisoning With Baclofen in Alcohol Use Disorder? Current Updates
por: Franchitto, Nicolas, et al.
Publicado: (2018) -
Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review
por: Rolland, Benjamin, et al.
Publicado: (2018) -
Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder
por: Simon, Nicolas, et al.
Publicado: (2018) -
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
por: de Beaurepaire, Renaud, et al.
Publicado: (2019) -
Baclofen in alcohol use disorder: An analysis of the data provided by the French “Temporary Recommendation for Use” 2014–2017 cohort
por: de Beaurepaire, Renaud, et al.
Publicado: (2022)